Tourette's

Horizontal Tabs

Introduction

Tourette's Syndrome is a neuropsychiatric disorder that is marked by a collection of motor- and vocal tics. Tourette's is inherited and is believed to result from dysfunctional cortical and subcortical regions in the brain. Since the mechanism behind the development of Tourette's is unknown it is difficult to predict the therapeutic potential of cannabinoids. However, many patients report significant symptomatic relief after (self-)administration of cannabis, suggesting cannabinoids can be used to (help) treat Tourette's.

Alternative Names

Gilles de la Tourette Syndrome

Group

Tags

Wiki Entry

Horizontal Tabs

Phytocannabinoids

THC

Top Right

Prescription Advice

Preclinical data suggests THC may be therapeutic in the treatment of Tourette's.

Given the nature of the disease, oral application or sublingual application may be beneficial. Also, smoked or inhaled THC (cannabis) may be beneficial.

For inhalation, inhale until the symptoms subside or the side-effects become intolerable.

For oral/sublingual application, please follow generic prescription advice.

Please note that, while based on preclinical and/or clinical research, this prescription advice is solely intended as a guideline to help physicians determine the right prescription. We intend to continuously update our prescription advice based on patient and/or expert feedback. If you have information that this prescription advice is inaccurate, incomplete or outdated please contact us here.

Related Disorders

Similar Entries

Horizontal Tabs

Clinical Trials

Self-medicating patients (n=47) reported symptomatic relief from Tourette’s after consumption of nicotine (7%), alcohol (69%) or cannabis (85%), indicating therapeutic potential for cannabinoids in Tourette’s (Müller-Vahl et al., 1997). In a 17-patient trial, 6 weeks of treatment with up to 10 mg THC/day produced significant symptomatic relief (Müller-Vahl et al., 2003).

Several single-patient case reports mention significant to complete symptomatic relief after using cannabis (see references within: Kluger et al., 2015).

Literature:

Kluger, B., Triolo, P., Jones, W., and Jankovic, J. (2015). The therapeutic potential of cannabinoids for movement disorders. Mov. Disord. Off. J. Mov. Disord. Soc.

Müller-Vahl, K.R., Kolbe, H., and Dengler, R. (1997). [Gilles de la Tourette syndrome. Effect of nicotine, alcohol and marihuana on clinical symptoms]. Nervenarzt 68, 985–989.

Müller-Vahl, K.R., Schneider, U., Prevedel, H., Theloe, K., Kolbe, H., Daldrup, T., and Emrich, H.M. (2003). Delta 9-tetrahydrocannabinol (THC) is effective in the treatment of tics in Tourette syndrome: a 6-week randomized trial. J. Clin. Psychiatry 64, 459–465.